Reaction
Her-2 Positive Breast Cancer reporting signals
As of the last recalculation, Her-2 Positive Breast Cancer appears in 141 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is TRASTUZUMAB (PRR 289.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Trastuzumab | 69 | 289.6 | 289.9 |
| Ado-Trastuzumab Emtansine | 13 | 250.6 | 251.0 |
| Lapatinib | 13 | 136.1 | 136.3 |
| Pertuzumab | 21 | 133.8 | 133.9 |